Peer Review History
| Original SubmissionNovember 11, 2024 |
|---|
|
Dear Dr. pruksanusak, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 04 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Athanasios G. Pantelis Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: “Prince of Songkla University” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and in Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. 6. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: This is a scientifically sound and generally well-written manuscript on a novel subject. Moreover, the novelty of the topic was one of the main reasons the peer review process took longer than usual. Please address all reviewers' suggestions individually and submit your response within 10 (ten) days. Alternatively, you may propose a different timeframe for revisions, provided it is reasonable. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1. Line 109-110: The authors mentioned exclusion criteria -- As this is a study about the reliability, I don't see why the authors had to exclude these women. If the study is a part of other studies that require these exclusion criteria, the authors should clarify. 2. Line 118: "(operator 1 and 2, operator 1 and 3, and operator 2 and 3)" gives meaning of each participant receive U/S from 3 sonographers, the authors might consider change to "(operator 1 and 2, operator 1 and 3, 'or' operator 2 and 3)." 3. The authors might consider mention about probe pressure during the measurement. 4. The authors might consider clarify more about the position of the U/S probe for the "cervix-placenta view" 5. Table 2 - misspelling "Wight circumference" 6. The method section mentioned Bland-Altman plots; however, I could not find the plot in the result section. The authors might rephrase the method section to make it align. Reviewer #2: Thank you for asking me to review the manuscript entitled “Assessing the Reliability of Abdominal Adiposity Measurements by Transabdominal Ultrasound in First Trimester Pregnancies with Sonographers of Varying Experience Levels.” Abstract: The abstract is well written Introduction: Well written, however, I wonder why the authors refer to the in-text citation before citing examples (ref 1-2), (ref 3), and (ref 4-6). It is already known that the references are captured in the brackets, so there is no need to add ref to it! Materials and Methods: This was well written, however, what advised the choice of statistical analysis used by the authors? Was there a test for normality on the data before deciding which statistical analysis to use? Did the authors run a positive and negative predictive values test for the study to determine the reliability of Ultrasound in adiposity biometry? Results: The result presentation is not very clear! It started with Table 2? The information in Table 1 can be captured as figures and table 1 should tell us about the demographic characteristics of the study population. What advised the selection of only 90 participants? The tables are not self-explanatory, the lines within the tables should be removed! Discussion: This is well presented, however, the authors in making reference to intext citations mention both the initial and surnames of the authors like “NJ Kennedy et al. and Nassr AA et al. Which I think is incorrect, it should either be Kennedy et al., or Nassr et al.,. The discussion is somewhat narrow or shallow, can authors expand on the discussion please? ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Dear Dr. pruksanusak, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== One reviewer has recommended rejecting your manuscript due to methodological concerns and questions regarding the generalizability of your findings to clinical practice, while another has advised major revision. In this context, you are encouraged to address these concerns thoroughly before your manuscript can proceed to the next stage of evaluation. ============================== Please submit your revised manuscript by Jun 21 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Athanasios G. Pantelis Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #3: (No Response) Reviewer #4: (No Response) Reviewer #5: All comments have been addressed Reviewer #6: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: No ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #3: (No Response) Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes Reviewer #6: Yes ********** Reviewer #3: I have 2 main concern: why did you select the first trimester? was it based on previous reports? we know that the fat deposits increase through second and third trimester, and these are the periods where pregnant women develop the actual insulin resistance. The second concern is the age. If you included younger women at 20th for example, this can remove the age factor of fat deposition. Also I wonder why did you select different levels of trainees to do the abdominal scan. As a first report in the country, you should put a solid background for future researches by conducting your study with expert hands. Also why did you excluded hypertensive women, hypertension alone has no impact on fat deposition unless itis related to obesity or diabetes Reviewer #4: Gestational diabetes mellitus is a significant problem, and one of its risk factors is central obesity. A common tool for assessing body composition (BMI) does not capture central obesity, and thus is an imprecise indicator of the risk of GDM. In this study, the authors use ultrasound to measure central obesity in pregnant Asian people. Their aim in this study is to quantify the extent to which a clinician’s level of experience affects the reliability of ultrasonic measurements of body fat taken in three different areas where fat is deposited in the trunk. The results indicate that the ultrasonic measurements of body fat correlate well with hip-to-waist ratio, hip circumference, and waist circumference. Moreover the degree of intra- and inter-clinician variability in taking these measurements is quite minimal. The paper is clearly written. The authors clearly and convincingly describe the shortcomings of BMI as a diagnostic tool, and present a convincing case in favor of new techniques to measure fat deposition in the trunk and thus more readily identify women at risk of GDM. The statistical methods appear sound, and the methods are clear. Table 1 is especially strong, as it shows exactly what differentiates the measurements taken at the different abdominal sites. In Tables 3 and 4 it is tricky to discern the most important comparisons the authors wish to draw our attention to. I wonder if every pairwise comparison needs to be presented. A summary could serve well, alternatively, the data in Tables 3 and 4 could perhaps be offered as supplemental materials. I have one primary concern, which is that the findings of the manuscript on inter-practitioner variability don’t clearly stand on their own. That is, the results described in this manuscript on inter-sonographer variability would be a crucial component of a larger study establishing the validity, relevance, or predictive value of the method itself. Such a methods paper might look at whether or not abdominal ultrasound compared favorably to other methods of measuring body composition such as body densitometry, CT, or MRI. Or, as seems to be the case here (based on my reading of an earlier response to reviewers), such a methods paper might look at the predictive value of ultrasound in assessing the risk of gestational diabetes. But these findings on measurement variability alone are presently separated from a context in which they would become compelling, and reach a wider audience. Reviewer #5: Summary This study is significant and has relevance in maintaining the health of both the mother and fetus. The aim and objective of the study were achieved through the different methods, results and the discussion. The study targeted the right subjects and the tools were non-invasive which made the methods more attractive. And elicited low or no discomfort to the pregnant women during their applications. Abstract Can the reason why these tools were considered be incorporated in the abstract? Yes, it is to measure the abdominal adiposity in pregnancy. But why? Line 28…. Let the correlation between the measurement of the abdominal adiposity and gestational diabetes mellitus be incorporated. Introduction Line 66…. Gave the reasons why this study was conducted, however, I believe this tool would be used in conjunction with other known methods in determining/diagnosing gestational diabetes mellitus. Materials and Methods Line 119 – 122…. What informed you of these 3 locations for the measurements? Results Line 153 – 155…. The probability that the procedure and results would be affected by experience of the operators was expected to be high as rightly indicated in this study. However, line 158, interestedly showed that VFT was not affected by experience. Discussion Line 181… this sentence should be reworded. ‘For Thai population, one study found similar results to ours with high intraobserver reliability (ICC 0.96)’ …. It could have be written as ‘our result was similar to a previous study which had a high intraobserver reliability’ (ICC 0.96). My understanding is that you compare new study with previous studies. Figures and Tables: They were simple, self-explanatory, easy to the eye and well labelled. Reviewer #6: 83- difference ---- it should be different 90-- research and contribute to the development of more effective GDM screening strategies---you are writing in introduction theseu/s technique for screeing of GDM --but already simple and reliable methods are there and only OBESITY is not the risk factor for GDM 118---------operators are not equally distributed as far as experence is concerned 121----- the cervix-placenta view need some explanaition how it measures and detect VF 190---------again your focus on prediction of GDM but can you explain that when other simple methods are availble then with this technique and it is obviuos experenced operator has more relable result so why the article only check the reliabilty of operators then authour did not mention that how much it has predictive value in screening GDM as your introduction is emaphasiszing on it ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #3: No Reviewer #4: No Reviewer #5: No Reviewer #6: Yes: professor farzana rizwan arain ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Assessing the Reliability of Abdominal Adiposity Measurements by Transabdominal Ultrasound in First Trimester Pregnancies with Sonographers of Varying Experience Levels PONE-D-24-49281R2 Dear Dr. Pruksanusak, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Athanasios G. Pantelis Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Dr. Pruksanusak and colleagues, Thank you for your detailed responses to the reviewers’ comments and for submitting the revised version of your manuscript titled: “Assessing the reliability of abdominal adiposity measurements by transabdominal ultrasound in first trimester pregnancies with sonographers of varying experience levels” (PONE-D-24-49281R2). I appreciate the effort you put into addressing the reviewers’ concerns. Your clarifications and the added content significantly enhance the manuscript’s clarity and value, particularly in reinforcing its methodological contribution to the field. I would like to offer my sincere apologies for the prolonged editing time and thank you for your patience throughout the process. Before proceeding to final acceptance, I kindly ask that you make a few minor language corrections to address small typographical and grammatical issues noted in the current version (e.g., “aimsT” in the Abstract, redundant phrasing in the Introduction, missing punctuation in the Discussion). Once these final edits are incorporated, your manuscript will be ready for publication. |
| Formally Accepted |
|
PONE-D-24-49281R2 PLOS ONE Dear Dr. pruksanusak, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Athanasios G. Pantelis Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .